XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.660
-0.045 (-2.64%)
At close: Nov 11, 2026, 4:00 PM EST
1.630
-0.030 (-1.81%)
After-hours: Nov 11, 2026, 4:10 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $5.42 million as of November 11, 2026. Its market cap has decreased by 44.80% in one year.
Market Cap
5.42M
Enterprise Value
5.34M
1-Year Change
-44.80%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $5.42M, a decrease of -97.15%. That is a compound annual growth rate of -15.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 5.42M | -23.94% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensysce Biosciences | 6.99M |
| Soligenix | 6.93M |
| Enveric Biosciences | 6.58M |
| FibroBiologics | 6.54M |
| Alzamend Neuro | 6.45M |
| Processa Pharmaceuticals | 6.23M |
| Lantern Pharma | 6.07M |
| Tempest Therapeutics | 6.00M |